Clinical Trials Logo

Dementia clinical trials

View clinical trials related to Dementia.

Filter by:

NCT ID: NCT05235113 Recruiting - Dementia Clinical Trials

Remote Game-based Exercise Program for Cognitive and Motor Function Improvement

Start date: November 3, 2023
Phase: N/A
Study type: Interventional

As our population ages, more older adults face motor-cognitive declines, increasing their risk of falls and fear of falling. Exercise is an effective way to maintain cognitive function, as supported by recent studies. However, those with poor motor and cognitive abilities often struggle to visit rehabilitation centers, leading to high dropout rates and low adherence to unsupervised programs. A remote exercise program tailored for individuals with cognitive impairments is urgently needed to preserve cognitive function, promote independent living, and reduce related costs. Researchers aim to develop an in-home system for adults with mild cognitive issues or dementia, designed to improve balance and cognition while being remotely supervised through telemedicine.

NCT ID: NCT05234866 Recruiting - Dementia Clinical Trials

Paradoxical Lucidity in Severe End-Stage Dementia

Start date: June 2, 2022
Phase:
Study type: Observational

Cognitive decline in dementia is considered irreversible, however episodes of paradoxical lucidity (PL) in severe dementia suggest other mechanisms may be in play. Beyond anecdotal reports of transient PL events occurring in patients predominantly in late-stage dementia and typically lasting anywhere from a few minutes to several hours, little is known about PL. The study team proposes to develop and conduct a mixed methods prospective study of PL during end stage advanced dementia, creating a definition and measurement scale for PL in advanced dementia, and identifying the potential electro cortical biomarkers of PL in advanced dementia. This study will be divided in two phases: Phase I and Phase II. During Phase I, the study team will collect sufficient and necessary data through an online survey and focus groups as well as assess the safety and feasibility of using symptom diaries (also known as daily trackers or journals) and real-time video EEG monitoring (vEEG). After preliminary review of the study procedures, the PI will decide whether to move onto the Phase II. The second phase will aim to expand the study population and refine study methods as well as create a definition and measurement scale for PL in advances dementia.

NCT ID: NCT05232526 Recruiting - Clinical trials for Dementia of Alzheimer Type

Imagery in Early Stages of Dementia

Start date: October 10, 2021
Phase: N/A
Study type: Interventional

The purpose of the present study is to investigate the effectiveness of mental imagery (MI) in subjects with early stage of dementia. The hypothesis of the study is that MI will have a beneficial effect in motor, cognitive and emotional state in this clinical population.

NCT ID: NCT05231954 Active, not recruiting - Clinical trials for Alzheimer Disease and Related Dementias (ADRD)

Digital Detection of Dementia (D Cubed) Studies: D2

Start date: July 5, 2022
Phase: N/A
Study type: Interventional

The specific aim of the pragmatic trial is to evaluate the practical utility and effect of the PDM, the QDRS, and the combined approach (PDM + QDRS) in improving the annual rate of new documented ADRD diagnosis in primary care practices.

NCT ID: NCT05227820 Completed - Alzheimer Disease Clinical Trials

Insulin-Sensitizing Anti-Inflammatory Small Molecule for Investigative Treatment of Dementia

Start date: January 19, 2022
Phase: Phase 2
Study type: Interventional

This study seeks to measure changes in cognition through verbal and visual test procedures and changes in biomarkers of Alzheimer's disease and inflammatory and metabolic parameters that can be measure in the central nervous system (CNS) with advanced neuroimaging techniques in patients treated with NE3107 (17a-ethynyl-androst-5-3b,7b,17b-triol).

NCT ID: NCT05225818 Withdrawn - Dementia Clinical Trials

Preparing Successful Aging Through Dementia Literacy Education And Navigation (PLAN)-Home

PLAN-Home
Start date: June 1, 2022
Phase: N/A
Study type: Interventional

Rapid growth in elderly population and higher prevalence of dementia necessitates further attention to dementia. Even though early detection and continuing care are mainstays of dementia care, limited access to dementia diagnosis and dementia care planning for elders could be attributed to factors like low dementia literacy-the capacity to obtain, process, and understand basic dementia-related information and services to make appropriate health decisions-and lack of social support. Developing innovative pathways to transition families of individuals with probable dementia into healthcare access for early diagnosis of dementia and timely dementia care planning can benefit patients and the patients' families. To this end, the investigators' study aims are to develop a home-based intervention program for dementia evaluation, education, and care planning and test its feasibility and acceptability in a pilot study.

NCT ID: NCT05225415 Active, not recruiting - Clinical trials for Dementia With Lewy Bodies

Study to Evaluate the Safety, Tolerability and Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies

COG1201
Start date: May 19, 2022
Phase: Phase 2
Study type: Interventional

Multi-center, randomized, double-blind, placebo-controlled, 6- month study in subjects with mild to moderate Dementia with Lewy Bodies.

NCT ID: NCT05222386 Recruiting - Parkinson Disease Clinical Trials

Community Outreach for Palliative Engagement -- Parkinson Disease

COPE-PD
Start date: April 26, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to learn more about the effectiveness of palliative care training for community physicians and telemedicine support services for patients and carepartners with Parkinson's disease and Lewy Body Dementia (LBD) or related conditions and their care partners. Palliative care is a treatment approach focused on improving quality of life by relieving suffering in the areas of physical symptoms such as pain, psychiatric symptoms such as depression, psychosocial issues and spiritual needs. Telemedicine is the use of technology that allows participants to interact with a health care provider without being physically near the provider.

NCT ID: NCT05217004 Completed - Dementia Clinical Trials

Evaluation of Mobile Apps for Informal Caregivers of People Living With Dementia

Start date: January 31, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effectiveness of two currently available apps for unpaid caregivers of people living with dementia.

NCT ID: NCT05209438 Recruiting - Dementia Caregivers Clinical Trials

Cereset Research Exploratory Study for Dementia Caregivers

Start date: June 16, 2022
Phase: N/A
Study type: Interventional

Caregivers of a person living with dementia (PLWD) experience high levels of prolonged stress that can lead to chronic problems with health, including increased risk of cardiovascular disease that is linked to autonomic dysregulation. Heart rate variability (HRV), measures of autonomic cardiovascular regulation, is decreased (worse) in caregivers of a person living with dementia. Autonomic function is linked to lateralization in the brain, and emerging neuromodulation methods that target lateralized signals in the brain, like Cereset (CR), may be able to improve heart rate variability. Therefore, this pilot study aims to test whether CR can improve HRV in caregivers of a person living with dementia experiencing stress, anxiety, or insomnia, as well as improve self-report measures of stress, sleep and caregiver burden.